Celsus Therapeutics Plc (CLTX) Exchange: NASDAQ

Data as of June 24, 2025

$36.01 ($16.33) 83.02%

Celsus Therapeutics Plc - Daily Information
Click for more stock information on Celsus Therapeutics Plc.
Daily Information Data
Date June 24, 2025
Open $19.69
Previous Close $36.01
High $36.94
Low $19.68
Adjusted Open $19.69
Previous Adjusted Close $36.01
Adjusted High $36.94
Adjusted Low $19.68

About Celsus Therapeutics Plc (CLTX)

DELISTED - Celsus Therapeutics Plc, a development stage biopharmaceutical company, engages in the discovery and development of non-steroidal, synthetic anti-inflammatory drugs. The company’s principal product candidate is MRX-6, a topical cream that is in Phase 2 clinical trial for the treatment of atopic dermatitis. Its product candidates in pre-clinical studies comprise OPT-1 for the treatment of conjunctivitis, post-operative inflammation, and/or dry eye; CFX-1 to treat cystic fibrosis; and OAX-1 for the treatment of osteoarthritis and other inflammatory diseases. The company was formerly known as Morria Biopharmaceuticals Plc and changed its name to Celsus Therapeutics Plc in June 2013. Celsus Therapeutics Plc was incorporated in 2004 and is headquartered in London, the United Kingdom.

Historical Stock Data for Celsus Therapeutics Plc (CLTX)

Date Open High Low Close Adj.Close Volume
2015-09-18 $19.69 $36.94 $19.68 $36.01 $36.01 67,652
2015-09-17 $20.10 $21.72 $18.66 $19.68 $19.68 40,167
2015-09-16 $1.99 $2.12 $1.99 $2.08 $2.08 83,495
2015-09-15 $2.04 $2.25 $2.01 $2.02 $2.02 44,942
2015-09-14 $2.25 $2.32 $1.91 $2.10 $2.10 56,275
2015-09-11 $2.09 $2.38 $2.08 $2.18 $2.18 78,961
2015-09-10 $1.99 $2.55 $1.94 $2.12 $2.12 575,606
2015-09-09 $1.90 $2.06 $1.90 $1.99 $1.99 61,479
2015-09-08 $1.95 $1.98 $1.87 $1.96 $1.96 70,338
2015-09-04 $1.91 $2.04 $1.78 $1.98 $1.98 164,964
2015-09-03 $2.18 $2.18 $1.88 $1.91 $1.91 184,836
2015-09-02 $2.47 $2.47 $2.08 $2.14 $2.14 275,617
2015-09-01 $2.55 $2.55 $2.43 $2.50 $2.50 182,665

Celsus Therapeutics Plc (CLTX) News Headlines

Recent Celsus Therapeutics Plc (CLTX) News
Similar Companies to Celsus Therapeutics Plc (CLTX) in the None Industry

All investments involve risks and is not suitable for every investor. The value of securities may fluctuate and as a result, clients may lose more than their original investment. The past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing.

No content on the Nuvestan website shall be considered a recommendation or solicitation for the purchase or sale of securities, options, or other investment products. All information and data on the website are for reference only, and no historical data shall be considered as the basis for judging future trends.

Terms of Use, features, support, and service options subject to change without notice.

Nuvestan Logo

© Nuvestan Inc.